Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Early use of fingolimod is associated with better clinical outcomes in relapsing–remitting multiple sclerosis patients — Miryam Cannizzaro (2022) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Early use of fingolimod is associated with better clinical outcomes in relapsing–remitting multiple sclerosis patients
Shared by
Massimo Filippi
Early use of fingolimod is associated with better clinical outcomes in relapsing–remitting multiple sclerosis patients
Article
2022
en
Authors
+8 more
MC
Miryam Cannizzaro
LF
Laura Ferrè
FC
Ferdinando Clarelli
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2021
Transcriptomic Analysis of Peripheral Monocytes upon Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients
Giacomo Sferruzza
,
Ferdinando Clarelli
,
Elisabetta Mascia
,
Laura Ferrè
,
Linda Ottoboni
,
Melissa Sorosina
,
Silvia Santoro
,
Lucia Moiola
,
Vittorio Martinelli
,
Gıancarlo Comı
,
Filippo Martinelli Boneschi
,
Massimo Filippi
,
Paolo Provero
,
Federica Esposito
Article
2020
Early evidence of disease activity during fingolimod predicts medium-term inefficacy in relapsing-remitting multiple sclerosis
Laura Ferrè
,
Andrea Mogavero
,
Ferdinando Clarelli
,
Lucia Moiola
,
Francesca Sangalli
,
Bruno Colombo
,
Vittorio Martinelli
,
Gıancarlo Comı
,
Massimo Filippi
,
Federica Esposito
Article
2022
Transcriptional Effects of Fingolimod Treatment on Peripheral T Cells in Relapsing Remitting Multiple Sclerosis Patients
Giacomo Sferruzza
,
Ferdinando Clarelli
,
Elisabetta Mascia
,
Laura Ferrè
,
Linda Ottoboni
,
Melissa Sorosina
,
Silvia Santoro
,
Massimo Filippi
,
Paolo Provero
,
Federica Esposito
Article
2017
Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability
Simone Migliore
,
Anna Ghazaryan
,
Ilaria Simonelli
,
Patrizio Pasqualetti
,
Ferdinando Squitieri
,
Giuseppe Curcio
,
Doriana Landi
,
Maria Giuseppina Palmieri
,
Filomena Moffa
,
Massimo Filippi
,
Fabrizio Vernieri
Article
2024
Effects of fingolimod on focal and diffuse damage in patients with relapsing–remitting multiple sclerosis – The “EVOLUTION” study
Massimo Filippi
,
Elisabetta Pagani
,
Renato Turrini
,
Marta Bartezaghi
,
Vincenzo Brescia Morra
,
Giovanna Borriello
,
Valentina Torri Clerici
,
Massimiliano Mirabella
,
Livia Pasquali
,
Francesco Patti
,
Rocco Totaro
,
Paolo Gallo
,
Maria A. Rocca
Discussion(0)
No comments yet. Be the first to comment.